Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?

Koren, Gideon; Matsui, Doreen; Einarson, Adrienne; Knoppert, David; Steiner, Meir
May 2005
CMAJ: Canadian Medical Association Journal;5/24/2005, Vol. 172 Issue 11, p1457
Academic Journal
Discusses the pattern of neonatal symptoms observed after maternal use of selective serotonin or serotonin-norepinephrine reuptake inhibitors. Symptoms of poor neonatal adaptation to antidepressants; Difference between withdrawal and serotoninergic syndrome; Adverse effects of untreated depression during pregnancy. INSETS: Symptoms of poor neonatal adaptation;Adverse effects of untreated depression during pregnancy.


Related Articles

  • A Prozac pregnancy? AOOSTA, KIM SCHWORM // Fit Pregnancy;Dec2012/Jan2013, Vol. 19 Issue 5, p19 

    The article discusses ill effects of taking antidepressants during pregnancy. It has been informed that studies suggest that the most commonly prescribed antidepressant Selective Serotonin Reuptake Inhibitors (SSRIs) during pregnancy could result in an increased risk of high blood pressure and...

  • Antidepressant Medications in Pregnancy.  // American Family Physician;12/1/2004, Vol. 70 Issue 11, preceding p2195 

    Discusses the safest and most effective antidepressant therapy in pregnant women. Use of selective serotonin reuptake inhibitors (SSRIs) as well as tricyclic antidepressants (TCAs); Comparison of these two methods of therapy; Analysis of several studies; Recommendation for labeling changes by...

  • Antidepressant risk seen as low.  // Fit Pregnancy;Apr/May2008, Vol. 15 Issue 1, p23 

    The article discusses research on taking antidepressants during pregnancy. Researchers showed that when used in the first trimester, the selective serotonin reuptake inhibitor (SSRI) class of antidepressants, which includes Celexa, Paxil, Prozac and Zoloft, was linked to particular defects,...

  • Pregnancy outcome adversely affected by antidepressants.  // Nursing Standard;10/25/2006, Vol. 21 Issue 7, p17 

    The article reports that pregnancy outcome is adversely affected by antidepressants, one study based in Great Britain suggests. Results showed that women who take selective serotonin reuptake inhibitors for depression during pregnancy are at risk of having low birth-weight babies with...

  • SSRIs during pregnancy may cause neonatal withdrawal syndrome.  // Contemporary OB/GYN;May2005, Vol. 50 Issue 5, p18 

    Discusses research being done on selective serotonin reuptake inhibitors (SSRI) in pregnant women and neonatal syndrome. Reference to a study by E. J. Sanz, C. De-las-Cuevas, A. Kiuru et al, published in the 2005 issue of the "Lancet"; Correlation between the risks of neonatal convulsions and...

  • Fluoxetine, a selective serotonin reuptake inhibitor modulates inflammatory and neuropathic pain in the rat. Pal Singh, Vijay; Jain, Naveen K.; Kulkarni, S. K. // Inflammopharmacology;2002, Vol. 9 Issue 3, p219 

    The clinical usefulness of classical tricyclic antidepressants has been indicated in a variety of neuropathic pain. The role of selective serotonin reuptake inhibitors (SSRIs) is, however, controversial in pain control. The present study was aimed at evaluating the efficacy of an SSRI,...

  • Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic... Anderson, I.M.; Tomenson, B.M. // BMJ: British Medical Journal (International Edition);6/3/95, Vol. 310 Issue 6992, p1433 

    Assesses treatment discontinuation rates with serotonin reuptake inhibitors compared with tricyclic antidepressants. Results of the meta-analysis of randomized controlled trials; Difference in toleration levels.

  • Use of SSRIs, SNRIs increasing in Northern Italy.  // PharmacoEconomics & Outcomes News;8/24/2013, Issue 685, p6 

    The article discusses a study conducted in Emilia Romagna, Italy, which found that the use of serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor antidepressants has significantly increased from 2006 to 2011.

  • Neonatal Signs After Late In Utero Exposure to Serotonin Reuptake Inhibitors: Literature Review and Implications for Clinical Applications. Moses-Kolko, Eydie L.; Bogen, Debra; Perel, James; Bregar, Amy; Uhl, Kathleen; Levin, Bob; Wisner, Katherine L. // JAMA: Journal of the American Medical Association;5/18/2005, Vol. 293 Issue 19, p2372 

    Context A neonatal behavioral syndrome linked to in utero serotonin reuptake inhibitor (SRI) exposure during the last trimester of pregnancy has been identified. The US Food and Drug Administration (FDA) and drug manufacturers have recently agreed to a class labeling change for SRIs, which...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics